P.A.W. Capital’s Pfizer PFE Stock Holding History

P.A.W. Capital’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.98M	Sell	82,200 -1,050	-1%	-$27.5K	1.52%	34
2026 Q1	$2.3M	Buy	+83,250	New	+$2.22M	1.84%	22
2022 Q4	–	Sell	-18,000	Closed	-$788K	–	47
2022 Q3	$788K	Hold	18,000	–	–	1.18%	34
2022 Q2	$944K	Hold	18,000	–	–	1.37%	16
2022 Q1	$932K	Buy	18,000 +2,000	+13%	+$104K	0.97%	36
2021 Q4	$945K	Sell	16,000 -2,000	-11%	-$99.1K	0.87%	28
2021 Q3	$774K	Sell	18,000 -4,000	-18%	-$177K	0.69%	51
2021 Q2	$862K	Hold	22,000	–	–	0.72%	38
2021 Q1	$797K	Buy	22,000 +4,000	+22%	+$142K	0.7%	42
2020 Q4	$663K	Sell	18,000 -972	-5%	-$35.7K	0.58%	52
2020 Q3	$661K	Sell	18,972 -2,108	-10%	-$73.9K	0.72%	34
2020 Q2	$654K	Buy	21,080 +2,635	+14%	+$89.5K	0.74%	34
2020 Q1	$571K	Hold	18,445	–	–	0.77%	38
2019 Q4	$686K	Hold	18,445	–	–	0.73%	43
2019 Q3	$629K	Buy	18,445 +2,635	+17%	+$95.8K	0.78%	47
2019 Q2	$650K	Hold	15,810	–	–	0.7%	48
2019 Q1	$637K	Hold	15,810	–	–	0.63%	48
2018 Q4	$655K	Sell	15,810 -1,054	-6%	-$43.8K	0.82%	33
2018 Q3	$705K	Sell	16,864 -2,108	-11%	-$81.2K	0.75%	40
2018 Q2	$653K	Sell	18,972 -2,108	-10%	-$72K	0.66%	44
2018 Q1	$710K	Hold	21,080	–	–	0.85%	34
2017 Q4	$724K	Hold	21,080	–	–	0.91%	39
2017 Q3	$714K	Hold	21,080	–	–	0.75%	58
2017 Q2	$672K	Hold	21,080	–	–	0.67%	62
2017 Q1	$684K	Hold	21,080	–	–	0.69%	61
2016 Q4	$650K	Hold	21,080	–	–	0.73%	53
2016 Q3	$677K	Hold	21,080	–	–	0.73%	46
2016 Q2	$704K	Hold	21,080	–	–	0.81%	42
2016 Q1	$593K	Hold	21,080	–	–	0.67%	55
2015 Q4	$646K	Hold	21,080	–	–	0.73%	52
2015 Q3	$628K	Hold	21,080	–	–	0.72%	51
2015 Q2	$671K	Hold	21,080	–	–	0.68%	52
2015 Q1	$696K	Sell	21,080 -1,054	-5%	-$33.5K	0.69%	49
2014 Q4	$654K	Hold	22,134	–	–	0.69%	53
2014 Q3	$621K	Hold	22,134	–	–	0.58%	59
2014 Q2	$623K	Hold	22,134	–	–	0.62%	58
2014 Q1	$675K	Hold	22,134	–	–	0.66%	49
2013 Q4	$643K	Buy	22,134 +1,054	+5%	+$30.7K	0.57%	50
2013 Q3	$575K	Hold	21,080	–	–	0.49%	52
2013 Q2	$560K	Buy	+21,080	New	+$582K	0.47%	50

Other funds holding PFE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

P.A.W. Capital's PFE Position: Q2 2026 in Review

P.A.W. Capital reduced its Pfizer (PFE) stake by 1.3% in Q2 2026, selling an estimated $27.5K and leaving 82,200 shares worth $1.98M. The position accounts for 1.52% of the portfolio, ranked #34.

P.A.W. Capital first reported a position in PFE in Q2 2013 and has held it in 40 quarters since. The position peaked at $2.3M in Q1 2026. 2,827 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

P.A.W. Capital held 82,200 shares of Pfizer worth $1.98M as of Q2 2026.
P.A.W. Capital sold 1,050 Pfizer shares in Q2 2026, an estimated $27.5K.
Pfizer made up 1.52% of P.A.W. Capital's portfolio in Q2 2026, its #34 holding.
P.A.W. Capital first reported a position in Pfizer in Q2 2013 and has held it in 40 quarters since.
P.A.W. Capital's Pfizer position peaked at $2.3M in Q1 2026.
2,827 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on P.A.W. Capital's 13F filing for Q2 2026, filed 28 Jul 2026.